/
Clinical Highlights Clinical Highlights

Clinical Highlights - PDF document

jane-oiler
jane-oiler . @jane-oiler
Follow
358 views
Uploaded On 2015-10-04

Clinical Highlights - PPT Presentation

Vascular Closure Device VASCULAR CLOSURE Dr Curtis J Brasseur is the ViceChair of the Radiology Departmentat Berkshire Medical Center in Pitts ID: 149288

Vascular Closure Device VASCULAR CLOSURE Dr.

Share:

Link:

Embed:

Download Presentation from below link

Download Pdf The PPT/PDF document "Clinical Highlights" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Clinical Highlights Vascular Closure Device VASCULAR CLOSURE Dr. Curtis J. Brasseur is the Vice-Chair of the Radiology Departmentat Berkshire Medical Center in PittsÞ eld, MA which is a 300-plus bed, not-for-proÞ t institution with a staff of 15 in the Interventional procedures in the lab. Dr. Brasseur and the Interventional Radiology staff believe excellent clinical outcomes, improved lab efÞ ciencies Vascular Closure Device was introduced into select patients, Dr. Brasseur has been able to provide alternative Device to seal the femoral arteriotomy after an angiography procedure is complete. An example of such an experience is highlighted below. PATIENT HISTORY A 64 year-old female with a history of smoking, diabetes and CATHETERIZATION PROCEDURE AND TREATMENT Diagnostic angiography was performed by accessing the right common femoral artery (CFA) and inserting a 4F catheter. Angiography showed that this patient had bilateral iliac catheter was then exchanged for a 7F introducer sheath. A 7F introducer sheath was also used to access the left CFA. iliac lesions. Due to the patientÕs overall health and risk factors, Dr. Brasseur chose to treat the thrombus in a separate procedurethe following day. He sealed both the right and the left femoral Vascular Closure Device.The next day, the second stage of the intervention, thrombolysis of the clot in the LLE was completed, using tPA. Dr. Brasseur Device, using an antegrade approach. Thrombolytic tPA was administered and the clot was Devices to ensure hemostasis. The patient had PittsÞ eld, MA www.sjm.com St. Jude Medical14901 Deveau PlaceMinnetonka, MN 55345952 933 4700952 933 0307 FaxSt. Jude Medical Europe, IncThe Corporate VillageAvenue Da Vinci Iaan, 11 - Box F1B-1935 - ZaventemBelgium+32 2 774 68 11+32 2 772 83 84 FaxSt. Jude Medical Brasil, Ltda.Rua Frei, Caneca 1380-9¡ A-CJ91/92Sao Paulo - SP - BrasilCEP 01307-002+55 11 5080 5400+55 11 5080 5423 FaxSt. Jude Medical (Hong Kong) LimitedUnit 2701-07, COSCO TowerGrand Millenium Plaza183 QueenÕs RoadCentral, Hong Kong+852 2996 7688+852 2956 0622 Fax Vascular Closure Device product family, including the STS Plus, VIP and Evolution platforms, is indicated for use in closing aare not limited to: bleeding or hematoma, AV Þ stula or pseudoaneurysm, infection, allergic reaction, foreign body reaction, inß ammation, or edema.Angio-Seal, ST. JUDE MEDICAL, the nine-squares symbol and MORE CONTROL. LESS RISK. are trademarks and service marks of St. Jude ©2008StJdMdilIAllihtd ATRIAL FIBRILLATIONCARDIAC RHYTHM MANAGEMENTCARDIAC SURGERYCARDIOLOGYNEUROMODULATION Dr. Brasseur feels strongly that the Angio-Seal Devices allowed least amount of risk. Dr. Brasseur states, ÒWithout the effective Device, thrombolysis Device had not been used in the procedure, Dr. Brasseur and his staff would have treated this patient in a greater risk of complications. In particular, a 7F sheath would have Dr. Brasseur concludes, ÒThe Angio-Seal Device provided an hemostasis in a patient who received a potent thrombolytic (tPA) lying ß at for several hours; she was able to have the head of her bed Device provided the safest, most